This inventor holds 1 USPTO granted patent. Top assignee: Gruenenthal Gmbh. Active years: 2010.
Company Filing History:
Years Active: 2010
Title: Robert Hett: Innovator in Pharmaceutical Processes
Introduction
Robert Hett is a notable inventor based in Unteraegeri, Switzerland. He has made significant contributions to the field of pharmaceuticals, particularly in the development of processes for producing complex chemical compounds. His work is characterized by a commitment to innovation and excellence.
Latest Patents
Robert Hett holds a patent for a process titled "Process for producing (1RS,3RS,6RS)-6-dimethylaminomethyl-1-(3-methoxyphenyl)-cyclohexane-1,3-diol." This patent encompasses a method for producing either (1R,3R,6R)-6-dimethylaminomethyl-1-(3-methoxyphenyl)-cyclohexane-1,3-diol or (1S,3S,6S)-6-dimethylaminomethyl-1-(3-methoxyphenyl)-cyclohexane-1,3-diol, including mixtures of these compounds. He has successfully secured 1 patent for this innovative process.
Career Highlights
Robert Hett is currently employed at Grünenthal GmbH, a company renowned for its focus on pain management and innovative pharmaceutical solutions. His role at the company allows him to apply his expertise in developing new processes that enhance the efficacy of pharmaceutical products.
Collaborations
Throughout his career, Robert has collaborated with esteemed colleagues, including Helmut Heinrich Buschmann and Wolfgang Hell. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and advancements in pharmaceutical research.
Conclusion
Robert Hett's contributions to the field of pharmaceuticals through his innovative processes exemplify the impact of dedicated inventors in advancing medical science. His work continues to influence the development of effective treatments, showcasing the importance of innovation in healthcare.